JP2009538824A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009538824A5 JP2009538824A5 JP2009502755A JP2009502755A JP2009538824A5 JP 2009538824 A5 JP2009538824 A5 JP 2009538824A5 JP 2009502755 A JP2009502755 A JP 2009502755A JP 2009502755 A JP2009502755 A JP 2009502755A JP 2009538824 A5 JP2009538824 A5 JP 2009538824A5
- Authority
- JP
- Japan
- Prior art keywords
- amylin
- pharmaceutical composition
- disorder
- composition according
- dementia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2006/012601 WO2006105527A2 (en) | 2005-03-31 | 2006-03-31 | Amylin and amylin agonists for treating psychiatric diseases and disorders |
| PCT/US2006/038919 WO2007114838A1 (en) | 2006-03-31 | 2006-10-04 | Amylin and amylin agonists for treating psychiatric diseases and disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009538824A JP2009538824A (ja) | 2009-11-12 |
| JP2009538824A5 true JP2009538824A5 (cg-RX-API-DMAC7.html) | 2009-12-24 |
Family
ID=39876652
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009502755A Pending JP2009538824A (ja) | 2006-03-31 | 2006-10-04 | 精神疾患及び障害治療用アミリン及びアミリンアゴニスト |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP2010208A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2009538824A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20080106950A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2006341375B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2647568A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2008012666A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2007114838A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100204107A1 (en) * | 2007-09-11 | 2010-08-12 | Dorian Bevec | Use of urodilatin as a therapeutic agent |
| WO2009043469A2 (en) * | 2007-09-11 | 2009-04-09 | Mondobiotech Laboratories Ag | Use of pneumadin as a therapeutic agent |
| JP2011525895A (ja) * | 2008-06-25 | 2011-09-29 | ノボ・ノルデイスク・エー/エス | アミリン及びサケカルシトニンの誘導体化ハイブリッドペプチド |
| JP2013511287A (ja) | 2009-11-23 | 2013-04-04 | アミリン・ファーマシューティカルズ,リミテッド・ライアビリティ・カンパニー | ポリペプチド・コンジュゲート |
| BR112013007442A2 (pt) | 2010-09-28 | 2019-09-24 | Amylin Pharmaceuticals Llc | polipeptídeos construídos tendo duração de ação realçada |
| MX349054B (es) | 2010-09-28 | 2017-07-07 | Aegerion Pharmaceuticals Inc | Leptinas altamente solubles. |
| WO2012162547A2 (en) | 2011-05-25 | 2012-11-29 | Amylin Pharmaceuticals, Inc. | Long duration dual hormone conjugates |
| WO2012160212A1 (en) | 2011-05-25 | 2012-11-29 | Camurus Ab | Peptide controlled-release formulations |
| DK2729160T3 (da) | 2011-07-08 | 2019-07-01 | Aegerion Pharmaceuticals Inc | Manipulerede polypeptider, der har forbedret virkningstid og reduceret immunogenicitet |
| JP6006309B2 (ja) | 2011-07-08 | 2016-10-12 | アミリン・ファーマシューティカルズ, リミテッド・ライアビリティ・カンパニーAmylin Pharmaceuticals, Llc | 作用持続期間が増大し、免疫原性が減少した操作されたポリペプチド |
| JP7505713B2 (ja) | 2019-02-22 | 2024-06-25 | ロヨラ メリーマウント ユニバーシティ | アミロイドペプチドバリアント |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5234906A (en) | 1991-01-10 | 1993-08-10 | Amylin Pharmaceuticals, Inc. | Hyperglycemic compositions |
| HU222249B1 (hu) * | 1991-03-08 | 2003-05-28 | Amylin Pharmaceuticals Inc. | Eljárás amilin agonista peptidszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására |
| ES2108122T3 (es) * | 1991-05-24 | 1997-12-16 | Amylin Pharmaceuticals Inc | Composicion a base de amilina o de un analogo de amilina conteniendo opcionalmente insulina, para el tratamiento de la anorexia y de las patologias asociadas. |
| EP1750752A2 (en) * | 2003-11-20 | 2007-02-14 | Neuronova AB | Compounds and methods for increasing neurogenesis |
| US7399744B2 (en) * | 2004-03-04 | 2008-07-15 | Amylin Pharmaceuticals, Inc. | Methods for affecting body composition |
| KR20080003849A (ko) * | 2005-03-31 | 2008-01-08 | 아밀린 파마슈티칼스, 인크. | 비만 및 섭식 장애의 조절, 예방 및 치료를 위한 조성물 및방법 |
-
2006
- 2006-10-04 WO PCT/US2006/038919 patent/WO2007114838A1/en not_active Ceased
- 2006-10-04 KR KR1020087023804A patent/KR20080106950A/ko not_active Ceased
- 2006-10-04 JP JP2009502755A patent/JP2009538824A/ja active Pending
- 2006-10-04 CA CA002647568A patent/CA2647568A1/en not_active Abandoned
- 2006-10-04 EP EP06816288A patent/EP2010208A1/en not_active Withdrawn
- 2006-10-04 MX MX2008012666A patent/MX2008012666A/es active IP Right Grant
- 2006-10-04 AU AU2006341375A patent/AU2006341375B2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Fox et al. | Levodopa‐related motor complications—Phenomenology | |
| JP2007508236A (ja) | うつ病およびその他の情動障害を治療する方法 | |
| RU2011124515A (ru) | Лечение когнитивных расстройств (r)-7-хлор-n-(хинуклидин-3-ил) бензо[b] тиофен-2-карбоксамидом и его фармацевтически приемлемыми солями | |
| JP2007516193A5 (cg-RX-API-DMAC7.html) | ||
| MX2010009643A (es) | Derivados de 2-aminoquinolina como antagonistas del receptor 5-hidroxitriptamina (5a). | |
| Li et al. | The effects of donepezil on phencyclidine-induced cognitive deficits in a mouse model of schizophrenia | |
| JP2011515391A5 (cg-RX-API-DMAC7.html) | ||
| MX2010009403A (es) | Derivados de 2-aminoquinolina. | |
| Catapano-Friedman | Effectiveness of quetiapine in the management of psychotic depression in an adolescent boy with bipolar disorder, mixed, with psychosis | |
| Yumatov | Emotional stress: the dialectics of nature | |
| WO2010026110A3 (en) | 6-substituted benzoxazines as 5-ht-5a receptor antagonists | |
| Prater et al. | Johanson-Blizzard syndrome—a case study, behavioral manifestations, and successful treatment strategies | |
| MX2010009820A (es) | 2-aminoquinolinas como antagonistas del receptor 5-hidroxitriptamina 5a. | |
| Lee | Anti-platelet effects of artemisinin through regulation of cyclic nucleotide on collagen-induced human platelets | |
| Subhash et al. | Alterations in 5-HT1A receptors and adenylyl cyclase response by trazodone in regions of rat brain | |
| Salzman | Treat the Patient, Not the Rule Book…: The Art of Psychopharmacology! | |
| Yang et al. | Perioperative Nursing Experience with a Patient with Ketamine Cystitis. | |
| Thakur et al. | Dark Side of Cannabis: Impact on Mental Health and Rising Abuse | |
| Keeler | The Status of Psychedelic Microdosing: What We Know Now and What We Need to Find Out. | |
| Sararoodi et al. | The Relationship of History of Hypertension and Illness Cognitive Representation in Post-Myocardial Infarction. | |
| Martin et al. | Psychiatric treatments: an exciting new century | |
| Byarugaba | The Response of the Roman Catholic Church in South Africa to the Problems of HIV/AIDS In Light of the Modern Catholic Social Teaching. | |
| McKenna | BUT WHAT IF THE “FIELD” IS A MOTHER–BABY BEHAVIOURAL SLEEP LABORATORY? | |
| Najavits | The Case of Jared. | |
| Coughlan et al. | Crystal Methamphetamine-ICE |